We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Antibiotic Prophylaxis Reduces Risk for Postpartum Perineal Wound Complications

By HospiMedica staff writers
Posted on 24 Jun 2008
Women who received antibiotic prophylaxis had reduced rates of perineal wound complications by the second week after delivery, according to a new study.

Researchers at the Santa Clara Valley Medical Center (San Jose, CA, USA) conducted a prospective, randomized controlled trial that included 147 women who had third- or fourth-degree perineal tears after vaginal delivery. More...
The women were randomized to receive a single intravenous dose of a second-generation cephalosporin (64) or placebo (83) before repair of the perineal tears. Obstetricians and patients were blinded to study drug, and the perineum was examined for evidence of infection or breakdown both at the time of hospital discharge and at two weeks postpartum. Main outcomes were gross disruption or purulent discharge at the site of perineal repair by two weeks postpartum; 40 (27.2%) of the women did not return for their two-week appointment.

The study results showed that perineal wound complications developed in 4 (8.2%) of 49 patients who received antibiotics and 14 (24.1%) of 58 patients who received placebo. At two-week follow-up, there was purulent discharge from the perineal wound in 4% of women who had received antibiotics compared to 17% of those who had received placebo. The groups were similar in parity, incidence of diabetes, operative delivery, and third- versus fourth-degree lacerations. Some of the limitations of the study included early termination because of difficulty achieving desired enrollment number within a reasonable time, patients refusing study participation, and a high no-show rate at two weeks postpartum. The study was published in the June 2008 issue of Obstetrics & Gynecology.

"The anal sphincter is susceptible to trauma during a vaginal delivery. The use of operative vaginal delivery, especially in combination with midline episiotomy, has been associated with a significantly increased risk of anal sphincter trauma in both nulliparous and multiparous women,” concluded lead author Neena Duggal, M.D., and colleagues. "Our high failed-appointment rate and specific patient population may limit the generalizability of our conclusions. We await verification of our findings from future studies, which could also evaluate outcomes in lower-risk populations, as well as longer-term outcomes, such as fecal and flatal incontinence and sexual function and satisfaction.”

During vaginal delivery, complications may include third-degree lacerations extending into the capsule and muscle of the anal sphincter and fourth-degree lacerations extending through the sphincter and into the rectal mucosa. Infection at the repair site may compromise success of an anal sphincter repair, and breakdown of the perineal repair may lead to bowel incontinence, rectovaginal fistula, or sexual dysfunction. Even without clear evidence of perineal wound breakdown or infection, more than one quarter to one half of women report complications three to six months after repair, including incontinence of flatus and incontinence of stools.


Related Links:
Santa Clara Valley Medical Center

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.